Barclays (LON:BARC) analyst Lauren Lieberman maintained a Buy rating on Keurig Dr Pepper (NASDAQ:KDP) on Friday, setting a price target of $40, which is approximately 11.08% above the present share price of $36.01.
Lieberman expects Keurig Dr Pepper to post earnings per share (EPS) of $0.30 for the second quarter of 2021.
The current consensus among 7 TipRanks analysts is for a Moderate Buy rating of shares in Keurig Dr Pepper, with an average price target of $36.71.
The analysts price targets range from a high of $40 to a low of $30.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $3.12 billion and a net profit of $767 million. The company's market cap is $50.68 billion.
According to TipRanks.com, Barclays analyst Lauren Lieberman is currently ranked with 2 stars on a 0-5 stars ranking scale, with an average return of 1.3% and a 53.05% success rate.
Massachusetts-based Keurig Dr Pepper, Inc. operates as a non-alcoholic beverage company in the US and internationally. It operates through four segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages.